Drugs / Insulin Lispro Biphasic 25
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04023344 | Mar 2018 → Jan 2019 | type 2 diabetes mellitus | Geropharm | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Insulin Lispro Biphasic 25 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04023344 ↗ |
| Known as | GP40021 | “Efficacy and safety of GP40021 insulin lispro biphasic compared with Humalog Mix 25 in Type 2 diabetes mellitus patients.” PMID 33355484 ↗ Dec 2020 |
| Route | Subcutaneous | “Subcutaneus injections Insulin Lispro Biphasic 25” NCT04023344 ↗ |